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Assembling a Gene Regulatory Network
for Specification of the B Cell Fate
and their integration with signaling pathways represents
a major challenge.
Specification of the B cell fate involves the expression
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Karen L. Reddy,1 David W. Lancki,1
Rodney DeKoter,2 Matthias Kieslinger,3
of a set of B lineage-specific genes including mb-1, B29,Rudolf Grosschedl,3 and Harinder Singh1,*
5, and VpreB and the onset of ordered DNA rearrange-1Howard Hughes Medical Institute
ments of the immunoglobulin heavy chain (IgH) locusDepartment of Molecular Genetics and Cell Biology
catalyzed by Rag-1 and Rag-2. Early B cell developmentThe University of Chicago
is critically dependent on five transcriptional regulators,Chicago, Illinois 60637
PU.1, Ikaros, E2A, EBF, and Pax-5. Of these, EBF and2 Department of Molecular Genetics
Pax-5 function exclusively within the B lineage, whereasUniversity of Cincinnati College of Medicine
PU.1, Ikaros, and E2A are important in the developmentCincinnati, Ohio 45267
of additional hematopoietic lineages. Both E2A (E12/3 Max-Planck-Institute of Immunobiology
E47) and EBF are required for initiation of B cell develop-79108 Freiburg
ment. Targeted inactivation of the E2A or EBF genesGermany
results in a block to B cell development prior to the
onset of early B lineage gene expression and initiation
of DH-JH rearrangements (Bain et al., 1994; Lin andSummary Grosschedl, 1995; Zhuang et al., 1994). E2A, EBF com-
pound heterozygotes are compromised for expression
The generation of B lymphocyte precursors is depen- of several early B cell genes, notably Pax-5 (O’Riordan
dent on the combinatorial action of the transcription and Grosschedl, 1999). Pax-5 is not required for specifi-
factors PU.1, Ikaros, E2A, EBF, and Pax-5. Loss of PU.1 cation of the B cell fate. Pax-5/ pro-B cells express
results in a severe reduction in Flk2, IL-7R lymphoid early B lineage genes and undergo IgH recombination
progenitors as well as impaired expression of EBF and but exhibit extensive developmental plasticity (Nutt et
Pax-5. Restoration of EBF expression facilitates rapid al., 1997, 1999). Conditional inactivation of the Pax-5
generation of pro-B cells from PU.1/ progenitors. gene demonstrates that Pax-5 is continuously required
Molecular analysis suggests that PU.1 directly partici- to maintain B lineage commitment (Mikkola et al., 2002).
pates in regulation of the EBF gene. Although PU.1 is These studies suggest that specification of the B cell
dispensable for expression of most early B lineage fate is dependent on E2A and EBF while commitment
genes, it is required for CD45R/B220. Using EBF/ and its maintenance require Pax-5.
mutant progenitors, we show that EBF induces Pax-5 The functions of PU.1 and Ikaros in B cell development
and the early program of B lineage gene expression. are less well understood. PU.1 is essential for develop-
Importantly, Pax-5 does not rescue B cell development ment of both the lymphoid and myeloid lineages,
from either PU.1/ or EBF/ progenitors. Pax-5 ex- whereas the Ikaros proteins function primarily in the
pression and function are contingent on EBF. Based lymphoid lineages (Scott et al., 1994; Wang et al., 1996).
on these results, we propose a hierarchical regulatory PU.1 has been shown to regulate hematopoietic progen-
network for specification and commitment to the B itors and their progeny by controlling expression of vital
cell fate. cytokine receptors (DeKoter et al., 1998, 2002). The PU.1
mutation results in a profound block to B lymphopoiesis
with an absence of B lineage progenitors expressingIntroduction
early B lineage genes (DeKoter et al., 2002; Scott et al.,
1997). PU.1/ multipotential progenitors are defectiveHematopoietic cell fates appear to be specified by
in expression of the IL-7R chain. The interleukin-7 re-unique combinatorial sets of transcription factors. The
ceptor (IL-7R) is initially expressed primarily on lymphoidB lymphocytic and erythrocytic lineages are leading
progenitors and is important for the development of Bmodels for analyzing the regulatory networks that under-
and T lymphocytes (Kondo et al., 1997; Peschon et al.,lie the specification of cell fates. For both lineages, dis-
1994; Sudo et al., 1993). Although it is clear that IL-7Rtinct sets of transcription factors have been genetically
signaling plays a key role in the survival and proliferation
shown to be required for cell fate specification (Cantor
of B and T lineage cells, it is not essential for their
and Orkin, 2002; Schebesta et al., 2002). Cell fate choice
generation (Carvalho et al., 2001; Crompton et al., 1998).
in the hematopoietic system is also modulated by vari- Interestingly, retroviral transduction of the IL-7R chain
ous signaling pathways including Wnt, Notch, and cyto- in PU.1/ progenitors restored the development of
kines (Allman et al., 2002; Kondo and Weissman, 2000; CD19 B lineage precursors (DeKoter et al., 2002). How-
Reya, 2003). These signaling pathways may establish ever, the rescue was inefficient, suggesting additional
or modulate regulatory networks by inducing the ex- critical functions of PU.1 in B lymphocyte development.
pression or altering the activity of lineage-determining Flk2/Flt3 is a cytokine receptor that is selectively ex-
transcription factors (Dahl et al., 2003; Pui et al., 1999). pressed on primitive hematopoietic progenitors and
The characterization of such gene regulatory networks may function in promoting the lymphoid versus myeloid
cell fates (Matthews et al., 1991; Rosnet et al., 1991).
Upregulation of Flk2/Flt3 on bone marrow multipotential*Correspondence: hsingh@uchicago.edu
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progenitors is associated with loss of stem cell and were exclusively CD19 (Figure 1B). It was possible that
the related Ets family member Spi-B compensated formyeloid reconstitution potential in vivo, but also with
sustained lymphoid potential (Adolfsson et al., 2001). PU.1 in the EBF-transduced cultures (DeKoter et al.,
2002). However, the generation of CD19 IL-7-respon-Targeted inactivation of the flk2/flt3 gene results in a
severe deficiency in B lineage precursors (Mackar- sive progenitors was also restored by transduction of
EBF in PU.1/Spi-B/ FLPs (Supplemental Figure S1enhtschian et al., 1995). Furthermore, mice deficient in
Flk2/Flt3 ligand (FL) fail to develop normal numbers of at http://www.developmentalcell.com/cgi/content/full/
7/4/607/DC1/). Thus, EBF can bypass the requirementIL-7R lymphoid progenitors (Sitnicka et al., 2002). The
combined loss of Flk2/Flt3 and the IL-7R results in a for PU.1 in early B cell development in the absence of
Spi-B.profound block to both fetal and adult B cell develop-
ment (Sitnicka et al., 2003; Vosshenrich et al., 2003). Next, we addressed if EBF could restore expression
of early B lineage genes and IgH recombination in theInterestingly, PU.1/ hematopoietic progenitors have
reduced expression of Flk2/Flt3 transcripts (DeKoter et transduced cells. Since CD19 is a Pax-5 target gene, it
was likely that EBF-transduced progenitors expressedal., 2002).
In addition to the IL-7R and Flk2/Flt3 defects, PU.1/ Pax-5. Indeed, RT-PCR analysis revealed Pax-5 tran-
scripts in EBF-rescued pro-B cells (Figure 1C). We notehematopoietic progenitors are impaired in expression
of EBF and Pax-5 (DeKoter et al., 2002). We show that that in the PU.1- or EBF-transduced PU.1/ progenitors,
expression of EBF and Pax-5 transcripts was restoredin contrast with the IL-7R chain, transduction of EBF
facilitates the rapid generation of B cell precursors from to near wild-type levels (Supplemental Figure S2). Im-
portantly, the EBF-transduced cells expressed early BPU.1/ progenitors. This suggests that the block to B
cell differentiation in the PU.1/ embryos is due to im- lineage genes including mb-1, B29, VpreB, 5, Rag-1,
and Rag-2 (Figure 1C). Furthermore, these cells ex-paired expression of the EBF gene. PU.1 binds in vitro
and in vivo to a conserved site in the EBF gene. PU.1, pressed robust levels of germline I transcripts, demon-
strating that transcriptional activation of the IgH locusbut not EBF, is required for the generation of Flk2/Flt3,
IL-7R lymphoid progenitors and expression of CD45R/ is not dependent on PU.1 (Supplemental Figure S2). To
determine if expression of EBF was also sufficient toB220. EBF functions to induce Pax-5 and the early pro-
gram of B lineage gene expression. Complementation restore IgH recombination, we performed PCR analysis.
DH-JH rearrangements were readily observed in EBF-of PU.1/ and EBF/ progenitors reveals that Pax-5
function is contingent on EBF. Based on these results, rescued cells after 14 days, whereas both proximal and
distal VH-DJH rearrangements were detectable withinwe propose a hierarchical regulatory network for specifi-
cation and commitment to the B cell fate. 14–21 days (Figure 1D). Thus, EBF can restore B cell
differentiation through the pre-B cell stage in PU.1/
FLPs. These results demonstrate that the early programResults
of B cell gene expression is dependent on EBF, but not
PU.1. Furthermore, they imply that Pax-5 expressionEBF Restores Early B Cell Development in PU.1/
and function are contingent on EBF.Fetal Liver Progenitors
PU.1/ fetal liver hematopoietic progenitors (Lin FLPs)
PU.1 Is Required for Expression of CD45R/B220are deficient in expression of the EBF and Pax-5 genes.
PU.1 has been suggested to regulate CD45 expressionTherefore, we sought to determine if EBF and/or Pax-5
in a lineage-specific manner in myeloid lineage, but notcould bypass the requirement for PU.1 in B cell develop-
in lymphoid lineage, cells (Anderson et al., 2001). A hall-ment. Day 14.5 gestation PU.1/ and PU.1/ FLPs were
mark of early B lineage development is expression oftransduced with EBF or Pax-5 encoding retroviral vec-
the CD45 isoform CD45R/B220. Whereas PU.1/ cellstors. Following infection, the cells were plated on S17
rescued with PU.1 expressed CD45R/B220, PU.1/ cellsstromal cells with IL-7. Foci of IL-7-dependent proliferat-
transduced with EBF did not, as revealed by flow cytom-ing cells were observed within 4–6 days of transducing
etry and RT-PCR (Supplemental Figures S3A and S3B).EBF. No such cells were observed in Pax-5- or MIGR1-
These results demonstrate that PU.1 is required for thetransduced PU.1/ cultures. Transduction of EBF facili-
expression of CD45R/B220 in B lineage cells. To deter-tated the generation of IL-7R cells from the PU.1/
mine that PU.1 is necessary for expression of CD45progenitors (Figure 1A). The failure of Pax-5 to rescue
in hematopoietic progenitors, FLPs from PU.1/ andthe survival or proliferation of PU.1/ FLPs was not
PU.1/ embryos were stained with an antibody thatdue to inefficient expression of Pax-5. The Pax-5 virus
recognizes all forms of CD45 and analyzed by flow cy-expresses at sufficient levels to restore CD19 expres-
tometry and RT-PCR. As shown in Supplemental Figuression in Pax-5/pro-B cells (data not shown). These data
S3C and S3D, PU.1/ FLPs lack expression of CD45suggest that EBF can either induce IL-7R expression or
protein as well as transcripts. These data demonstraterapidly promote the expansion of a rare population of
that expression of CD45 and its isoform CD45R/B220IL-7R PU.1/ FLPs (see below).
are dependent on PU.1 in myeloid and B lineage cells.To determine the nature of the cells that were gener-
ated by EBF transduction, we harvested day 10–14 MIG-
EBF cultures and examined expression of the B lineage EBF, but Not IL-7R, Promotes Rapid Generation
of Pro-B Cells from PU.1/ FLPsmarker CD19 and the myeloid marker Mac-1. PU.1/
FLPs transduced with the MIGR1 virus generated CD19 The expression of the IL-7R and EBF genes is depen-
dent on PU.1. Intriguingly, either IL-7R or EBF canas well as Mac-1 cells, as did PU.1/ FLPs transduced
with the MIG-PU.1 virus (data not shown; DeKoter and restore production of CD19 B cell precursors from
PU.1/ FLPs in vitro (Figure 1B; DeKoter et al., 2002).Singh, 2000). In contrast, the MIG-EBF-transduced cells
Specification of the B Cell Fate
609
Figure 1. EBF Bypasses the Requirement for
PU.1 in Early B Cell Development
(A) IL-7R expression in EBF-transduced pro-
genitors. Comparative analysis of PU.1/
Lin FLP cells transduced with the MIGR1
virus or PU.1/ Lin FLP cells transduced
with the MIG-EBF virus. Cells were cultured
on S17 stromal cells with IL-7 for 10 days
and then FACS analyzed. The filled and open
histograms represent staining with anti-IL-7R
or an isotype control antibody, respectively.
(B) Cell cultures described in (A) were ana-
lyzed for expression of CD19, Mac-1, and
GFP. Quadrants were set based upon stain-
ing with appropriate isotype controls.
(C) RT-PCR analysis of B lineage gene ex-
pression in Lin cells isolated from PU.1/
and PU.1/ embryos, PU.1/ Lin cells
transduced with the MIGR1 virus, or PU.1/
Lin cells transduced with either MIG-PU.1
or MIG-EBF.
(D) Rearrangement of IgH loci in PU.1/ cells
transduced with the MIG-PU.1 or MIG-EBF
viruses. Genomic DNA from the indicated
cells was analyzed by PCR. Similar results
were obtained using primers to detect VH-DJH
rearrangements involving the 7183 (shown),
Q52, or J558 VH families. Data are represen-
tative of 3–5 independent experiments.
To compare the ability of IL-7R and EBF in bypassing cultures consist exclusively of IL-7-dependent myeloid
progenitors (data not shown and DeKoter et al., 2002).the requirement for PU.1 in B cell development, we per-
formed a kinetic analysis. PU.1/ FLPs were transduced Thus, EBF restores the development of B cell precursors
more rapidly than the IL-7R. These data suggest thatwith MIG-PU.1, MIG-EBF, or MIG-IL-7R viruses and
the cultures were analyzed periodically for the appear- the primary block in B cell differentiation observed in
PU.1/ progenitors is due to impaired EBF expression.ance of B cell precursors (Figure 2). Interestingly, CD19
cells were evident at the earliest time point analyzed in
PU.1/ cultures infected with MIG-PU.1 or MIG-EBF
viruses. As noted above, foci of proliferating cells were PU.1 Binds In Vitro and In Vivo to a Conserved
Site in the EBF Geneobserved in EBF-transduced cultures as early as day 4.
In stark contrast, the generation of CD19 cells after To explore if PU.1 directly regulates the EBF gene, we
pursued a bioinformatics approach. The genomic se-transduction with IL-7Rwas considerably delayed. We
note that at earlier time points, the IL-7R-transduced quences encoding the mouse and human EBF genes
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cells and EL-4 T cells. The IL-7R gene segment span-
ning a previously characterized PU.1 binding site was
included as a positive control (DeKoter et al., 2002). As
demonstrated in Figure 3C, PU.1 is bound in vivo to the
high-affinity site in the EBF gene. In contrast, three other
PU.1 binding sites in the EBF gene were not detectably
crosslinked in vivo (data not shown). Alignment of the
PU.1 binding site in the EBF gene with similar sites in
other PU.1 target genes reveals conservation of both
the core sequence and a 5 flanking tract of adenine
residues (Figure 3D). We note that such sites can acti-
vate PU.1-dependent transcription in transient assays
(DeKoter et al., 2002). Thus, we have identified a con-
served, high-affinity PU.1 binding site in the EBF geneFigure 2. Comparison of B Cell Generation by PU.1, EBF, and IL-7R
that is bound in vitro and in vivo in a pro-B cell line.PU.1/ Lin FLPs were isolated and transduced with MIG-PU.1,
MIG-EBF, or MIG-IL-7R viruses. The transduced cells were har- These data suggest that PU.1 can directly participate
vested at the indicated time points and FACS analyzed for percent- in regulating the expression of the EBF gene.
ages of GFP CD19 B lineage precursors. Data are representative
of two independent experiments.
PU.1 Is Needed for the Development of Early
Lymphoid Progenitorswere obtained from the Celera database and then ana-
To determine the efficiency of restoration of B cell devel-lyzed for conserved noncoding segments using the
opment by EBF, we analyzed PU.1/ FLPs transducedLagan/VISTA analysis program (http://lagan.stanford.
with PU.1, EBF, or IL-7R by limiting dilution (Supple-edu). A 390 bp fragment exhibiting 87% identity between
mental Table S1). We observed a 5-fold reduction in thethe mouse and human sequences was identified in the
frequency of progenitors that could be rescued withfirst intron. A putative PU.1 binding site was revealed
EBF or IL-7R compared to PU.1. Therefore, both EBFwithin this region by TRANSFAC (Figure 3A). Gel shift
and IL-7R restore B cell development from a moreassays using in vitro translated PU.1 (data not shown)
restricted set of PU.1/ FLPs than does PU.1.and nuclear extracts from 38B9 pro-B cells showed that
We have documented reduced Flk2/Flt3 transcriptsPU.1 bound to this site. We note that this site is bound
in PU.1/ FLPs (DeKoter et al., 2002). The reduced fre-by PU.1 with high affinity comparable to the B site
quency of PU.1/ progenitors rescued with EBF orin the Ig  enhancer (Figure 3B and data not shown;
IL-7R could be due to a reduction in Flk2/Flt3 express-Eisenbeis et al., 1993).
ing multipotential precursors. To examine this possibil-We used chromatin crosslinking and immunoprecipi-
ity, FLPs from PU.1/ and PU.1/ embryos were stainedtation to determine if this site was occupied by PU.1
in vivo. ChIP assays utilized chromatin from 38B9 pro-B with antibodies to c-kit, AA4.1, CD27, and Flk2/Flt3. This
Figure 3. PU.1 Binds In Vitro and In Vivo to
a Conserved Site in the EBF Gene
(A) Schematic alignment of a conserved re-
gion in the mouse and human EBF genes that
contains a high-affinity PU.1 binding site (la-
beled).
(B) Gel shift analysis of the PU.1 binding site
in the EBF gene. An oligonucleotide probe
containing the PU.1 binding site was incu-
bated with nuclear extracts from 38B9 pro-B
cells. PU.1 binding was assayed in the pres-
ence of a wild-type (B) or mutant (Bm1)
competitor oligonucleotide containing the
PU.1 binding site in the Ig  enhancer.
(C) In vivo crosslinking of PU.1 in 38B9 pro-
B cells. The formaldehyde-crosslinked chro-
matin was analyzed using PCR primers that
span the PU.1 sites in the EBF and IL-7R
genes. Data are representative of four inde-
pendent experiments.
(D) Sequence comparison of PU.1 high-affin-
ity binding sites in B and myeloid lineage
genes.
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IL-7R progenitors is severely diminished in PU.1/ em-
bryos (Figure 4B).
To determine if Flk2/Flt3 expression on FLPs corre-
lated with enhanced B cell potential, we performed lim-
iting dilution analysis. The B lineage precursor frequen-
cies of c-kit AA4.1 Flk2 and c-kit AA4.1 Flk2 FLPs
were compared. Using this assay, we observed a 4-fold
increase in B cell precursor frequency in c-kit AA4.1
cells expressing the Flk2/Flt3 receptor (Supplemental
Figure S4). In contrast, myeloid developmental potential
was increased only 2-fold in the Flk2 compared to the
Flk2 fraction (Supplemental Figure S4). Thus, acquisi-
tion of Flk2 expression correlates with enhanced B cell
precursor activity in fetal liver. Together with the data
presented above, these data suggest a profound block
in the development of lymphoid progenitors in PU.1/
embryos prior to IL-7R expression.
Next, we determined if the impaired development of
Flk2, IL-7R lymphoid progenitors in PU.1/ embryos
was due to lack of FL production by multipotential pro-
genitors. Using RT-PCR analysis, we found no defect
in expression of FL in PU.1/ FLPs (Supplemental Figure
S5). As expected, Flk2/Flt3 transcripts were diminished,
consistent with the flow cytometry data. These results
suggest that the impaired expression of Flk2/Flt3 recep-
tor, rather than its ligand, contributes to the B lymphoid
deficiency in PU.1/ embryos. The 5-fold reduction in
the frequency of PU.1/ FLPs that could be rescued by
EBF or IL-7R compared with PU.1 (Supplemental Table
S1) is correlated with the reduction in the Flk2/Flt3
compartment in PU.1/ embryos (Figure 4A). It is there-
Figure 4. Analysis of Lymphoid Progenitor Compartments in fore likely that EBF induces B cell differentiation from
PU.1/ and PU.1/ Embryos this rare population of mutant progenitors.
(A) Fetal liver Lin cells were isolated from PU.1/ and PU.1/
embryos and stained with antibodies to c-kit, AA4.1, CD27, and EBF Functions in B220 IL-7R Lymphoid
Flk2/Flt3. The c-kit AA4.1 cells (boxed regions in upper panels) Progenitors to Specify the B Cell Fate
were analyzed for expression of CD27 and Flk2/Flt3 (lower panels).
We have established that PU.1 is needed for the genera-Lymphoid progenitors are a subset of the c-kit AA4.1 multipoten-
tion of Flk2, IL-7R lymphoid progenitors (Figure 4). Totial cells that express both CD27 and Flk2/Flt3. Data are representa-
determine if defective EBF expression contributes totive of three independent experiments.
(B) Fetal liver Lin cells were stained with antibodies to c-kit and the loss of these progenitors in PU.1/ embryos, we
IL-7R. Data are representative of two independent experiments. examined the effect of the EBF mutation on the develop-
Quadrants were set based upon staining with appropriate isotype ment of such cells. Percentages of Flk2, IL-7R cells
controls. were essentially identical between wild-type and EBF/
embryos (Figures 5A and 5B). Therefore, the deficiency
of lymphoid progenitors in PU.1/ embryos is not due
combination was designed to resolve various multipo- to impaired expression of EBF. Furthermore, this data
tential progenitors (Cumano et al., 1992; Matthews et rigorously distinguishes the effect of the PU.1 mutation
al., 1991; Medina et al., 2001; Phillips et al., 2000). Ini- from that of the EBF mutation in the lymphoid develop-
tially, we compared frequencies of Lin c-kit AA4.1 mental compartment. Early B cell progenitors express
progenitors and found a 3-fold reduction in PU.1/ com- CD45R/B220. EBF/ embryos (day 14.5 gestation) have
pared to PU.1/ embryos (Figure 4A, 2%  1% versus B220 progenitors at frequencies comparable to their
7%  1%, respectively; Scott et al., 1997). Next, we wild-type counterparts (1.9%  0.9% versus 1.8% 
examined percentages of Lin c-kit AA4.1 cells ex- 0.4%, respectively, n  5 for each genotype). Given the
pressing CD27 and Flk2/Flt3. In PU.1/ fetal livers, presence of IL-7R B220 progenitors in EBF/ em-
53%  2% of Lin c-kit AA4.1 cells expressed CD27 bryos, we tested if they could be propagated on stromal
and Flk2/Flt3 (Figure 4A, bottom left). In contrast, only cells in the presence of IL-7 and stem cell factor (SCF).
12%  4% of Lin c-kit AA4.1 cells in PU.1/ fetal EBF/ cells readily proliferated in IL-7 and SCF. As
liver expressed CD27 and Flk2/Flt3 (Figure 4A, bottom shown in Figure 6A, the EBF/ progenitors were CD45R/
right). Taken together, these data reveal a significant B220 but did not express CD19. Thus, IL-7-responsive
decrease in Lin c-kit AA4.1 CD27 Flk2/Flt3 pro- CD45R/B220 cells can be readily expanded from
genitors in PU.1/ embryos compared to their wild-type EBF/ FLPs. This contrasts with the behavior of PU.1/
counterparts. Furthermore, the PU.1/ c-kit AA4.1 FLPs and is consistent with the view that PU.1 functions
CD27 cells expressed lower levels of the Flk2/Flt3 re- upstream of EBF to generate IL-7-responsive lym-
phoid progenitors.ceptor. As a likely consequence, the frequency of c-kit
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progenitors requires EBF. Furthermore, they demon-
strate that Pax-5 expression and function are contingent
on EBF.
Discussion
Using PU.1/ or EBF/ FLPs, we have attempted to
delineate the roles of the transcription factors PU.1,
EBF, and Pax-5 in the development of B cell precursors.
PU.1/ FLPs are defective in expression of EBF and
Pax-5, and herein we demonstrate that EBF can bypass
the requirement for PU.1 in early B cell development. In
addition, we provide evidence that PU.1 can participate
directly in regulating expression of the EBF gene. Impor-
tantly, we show that Pax-5 expression and function are
contingent on EBF. We also provide evidence for a
unique function of PU.1 in development of the lymphoid
progenitor compartment that cannot be executed by
EBF or the combinatorial action of EBF, E2A, and Ikaros.
Finally, by complementing EBF/ progenitors, we es-
tablish that EBF, but not Pax-5, is required for specifica-
tion of the B cell fate. These results lead us to propose
a gene regulatory network that orchestrates the devel-
opment of B lineage precursors.
PU.1, but not EBF, is important for development of
the c-kit AA4.1 CD27 Flk2/Flt3 compartment from
which fetal liver B lineage progenitors are generated
(Figures 4A and 5A). This analysis rigorously resolves
the functions of these two transcription factors in the
multipotential progenitor compartment. Multipotential
progenitors expressing Flk2/Flt3 are enriched for B lin-
eage developmental potential (Supplemental Figure S4),
Figure 5. Analysis of the Lymphoid Progenitor Compartment in and in vitro data suggests that ligation of Flk2/Flt3 pro-
EBF/ Embryos
motes IL-7R expression (Adolfsson et al., 2001; Borge
(A) Lin cells from EBF/ or EBF/ embryos were stained with et al., 1999). B, but not myeloid lineage deficiencies,
antibodies to c-kit, AA4.1, CD27, and Flk2/Flt3. The c-kit AA4.1
have been found in both Flk2/Flt3 and Flk ligand (FL)cells (boxed regions in upper panels) were analyzed for expression
knockout animals (Mackarenhtschian et al., 1995; Sit-of CD27 and Flk2/Flt3 (lower panels). Lymphoid progenitors are a
nicka et al., 2002). The combined loss of Flk2/Flt3 andsubset of the c-kit AA4.1 multipotential cells that express both
CD27 and Flk2/Flt3. Data are representative of two wild-type and IL-7R signaling results in failure to develop fetal as well
three EBF/ embryos. as adult B cell precursors (Sitnicka et al., 2003; Vosshen-
(B) Fetal liver mononuclear cells from wild-type or EBF/ embryos rich et al., 2003). Importantly, both Flk2/Flt3 and IL-
were stained with antibodies to c-kit and IL-7R. Data are representa-
7R transcripts are severely reduced in PU.1/ FLPstive of two wild-type and three EBF/ embryos.
(Supplemental Figure S5; DeKoter et al., 2002). We now
show a significant reduction in c-kit AA4.1 CD27
Flk2/Flt3 progenitors in PU.1/ embryos, and those
We next determined if restoration of EBF expression that are detectable express lower levels of the Flk2/
in EBF/ progenitors could induce the generation of B Flt3 receptor (Figure 4B). The reduction in Flk2/Flt3
cell precursors. FLPs from EBF/ embryos were trans- progenitors is not due to defective production of FL
duced with the MIGR1 or MIG-EBF retroviral constructs. (Supplemental Figure S5). These results suggest that
Transduction of EBF in the mutant progenitors induced PU.1 may regulate the expression of the Flk2/Flt3 gene
expression of CD19 (Figure 6B). Therefore, it was likely and thereby the survival/proliferation of Flk2/Flt3
that EBF-rescued progenitors expressed Pax-5. As lymphoid progenitors. Expression of Flk2/Flt3 is also
shown in Figure 6C, RT-PCR analysis revealed tran- dependent on Ikaros. Flk2/Flt3 mRNA is absent in both
scripts for Pax-5 and early B lineage genes. In contrast, Ikaros null and Ikaros DN/ Lin hematopoietic progeni-
MIGR1-transduced EBF/ progenitors lacked expres- tors (Nichogiannopoulou et al., 1999). Since Ikaros ex-
sion of Pax-5 and most early B lineage genes. Low levels pression is not impaired by the PU.1 mutation, we pro-
of B29 transcripts were detectable in the MIGR1-trans- pose that expression of Flk2/Flt3 may depend on
duced EBF/ cells. Importantly, EBF/ cells expressed concerted regulation by PU.1 and Ikaros (see model,
normal levels of PU.1, E2A, and IL-7R transcripts. Fi- Figure 7). Interestingly, the decreased frequency of Flk2/
nally, we note that transduction of Pax-5 in EBF/ pro- Flt3 lymphoid progenitors in PU.1/ embryos (Figure
genitors did not induce expression of CD19 in a signifi- 4A) correlates with our clonal analysis comparing the
cant fraction of cells (Figures 6B and 6D) nor bypass efficiency of EBF and PU.1 rescue (Supplemental Table
the requirement for EBF in induction of mb-1 expression S1). Thus, EBF may be restoring B cell development
(Figure 6D). Taken together, these results establish that from the PU.1/ c-kitAA4.1 CD27Flk2/Flt3 popula-
tion. In contrast, PU.1 could function in a less restrictedinduction of early B lineage gene expression in lymphoid
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Figure 6. EBF but Not Pax-5 Restores B Cell
Differentiation in EBF/ FLPs
(A) Lin cells from EBF/ and EBF/ em-
bryos were isolated and plated on S17 stro-
mal cells in medium containing IL-7 and SCF.
Day 10–14 cultures were harvested and ana-
lyzed for expression of CD45R/B220 and
CD19.
(B) Comparative analysis of EBF/ Lin cells
transduced with MIGR1, MIG-EBF, and MIG-
Pax5 viruses. Transduced cultures were har-
vested after 10–14 days and analyzed for ex-
pression of GFP, CD45R/220, and CD19. The
dotplots shown are gated on GFP cells. Data
in (A) and (B) are representative of four inde-
pendent experiments.
(C) RT-PCR analysis of B lineage gene ex-
pression in EBF/ progenitors after transduc-
tion with the MIGR1 or MIG-EBF viruses. Data
are representative of three independent ex-
periments. Wild-type Lin cells infected with
the MIGR1 virus and differentiated into pro-
B cells were used as a control.
(D) Semiquantitative RT-PCR analysis of ex-
pression of Pax-5 target genes in EBF/ cul-
tured fetal liver progenitors transduced with
the MIGR1, MIG-EBF, or MIG-PAX5 retroviral
constructs. Wild-type Lin cells infected with
the MIGR1 virus and differentiated into pro-
B cells were used as a control. Data are repre-
sentative of results obtained after transduc-
tion of three independent EBF/ lines.
progenitor population to induce Flk2/Flt3 and IL-7R ex- pro-B cells (Figure 1). EBF and E2A synergistically acti-
vate transcription of early B lineage genes (O’Riordanpression, thereby restoring the lymphoid progenitor
compartment and subsequently EBF-dependent B cell and Grosschedl, 1999; Sigvardsson et al., 1997). Further-
more, EBF and E2A can induce specific DNA rearrange-differentiation (Figure 7). Based on these considera-
tions, PU.1 would be predicted to be more efficient at a ments of Ig loci when ectopically expressed with Rag-1
and Rag-2 in nonlymphoid cells (Romanow et al., 2000).clonal level in restoring B cell development from PU.1/
FLPs than EBF (Supplemental Table S1). E2A has been implicated in regulating EBF expression
(Kee and Murre, 1998). The EBF promoter contains aTransduction of EBF in PU.1/ FLPs facilitates IL-7-
dependent proliferation, early B lineage gene expres- functional binding site for E2A (Smith et al., 2002). Re-
cently, it was shown that E47/ FLPs do not expresssion, and IgH recombination, hallmarks of specified
Figure 7. A Hierarchical Regulatory Network
for Specification of the B Cell Fate
Four key developmental states are depicted.
Each state is dictated by a distinctive combi-
nation of regulatory molecules (transcription
factors and receptors). Regulatory connec-
tions (hatched or solid arrows) are based on
experimental evidence presented herein or
described in the literature (see Discussion).
The cell surface phenotypes of the multipo-
tential progenitor, the lymphoid progenitor,
the specified pro-B cell, and the committed
pro-B cell are CD45 c-kit CD27 AA4.1
Flk2, CD45 c-kit CD27 AA4.1 Flk2 IL-
7R, CD45R IL-7R, and CD45R IL-7R
CD19, respectively. The specified pro-B cell
expresses B29, mb-1, 5, VpreB, and Rag1/2.
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EBF and restoration of EBF expression promotes the functional EBF binding sites in the Pax-5 promoter (Fig-
ures 1C and 6C; O’Riordan and Grosschedl, 1999). How-generation of B cell precursors (Seet et al., 2004). These
results support the contention that expression of the ever, Pax-5 does not appear to reciprocally regulate
expression of the EBF gene. Deletion of Pax-5 in pro-EBF gene is regulated by E2A proteins. Furthermore,
they suggest that EBF can function synergistically with B cells does not impair EBF expression (Souabni et al.,
2002). In our experiments, Pax-5 was unable to rescuelow levels of alternative E proteins to regulate the early
B lineage program of gene expression. We have charac- B cell development from PU.1/ progenitors. Consistent
with our results, EBF, but not Pax-5, could promote theterized a high-affinity PU.1 binding site in the EBF gene
that is bound both in vitro and in vivo in a pro-B cell generation of B cell precursors from E47/ FLPs (Seet
et al., 2004). Thus, Pax-5 function is contingent on EBF.line (Figure 3). This site is located within the first intron
in a conserved region between the mouse and human Furthermore, Pax-5 cannot induce EBF in either PU.1/
or E47/ FLPs. Recently, it has been proposed thatEBF genes. The conserved region may represent an
enhancer or an alternative EBF promoter since the trans- Pax-5 can positively regulate the EBF gene (Fuxa et al.,
2004). In these experiments, precocious Pax-5 expres-lational initiation codon resides in exon 2. Functional
analyses are being pursued to test these possibilities. sion in the hematopoietic system resulted in thymocytes
that express EBF. However, the developmental and mo-It remains possible that expression of the EBF gene is
indirectly regulated by PU.1. Nevertheless, the current lecular basis of this finding remains to be explored.
It is intriguing that either a key transcriptional regulatorresults lead us to propose that the developmental induc-
tion of EBF expression depends on the concerted action (EBF) or a cytokine receptor (IL-7R) can facilitate the
proliferation and differentiation of PU.1/ progenitorsof PU.1 and E2A (Figure 7). Once expressed, EBF to-
gether with E2A then functions to specify the B cell fate into B lineage precursors, albeit with very different kinet-
ics. Both EBF and IL-7R likely promote the generationby coordinately inducing the early program of B cell
gene expression. of B cell precursors from the same diminished PU.1/
multipotential progenitor population (c-kit AA4.1Our study reveals CD45R/B220 as a likely PU.1 target
gene in B lineage progenitors. PU.1/ CD19 cells res- CD27Flk2/Flt3; Figure 4). The transduced cells exhibit
a similar B lineage differentiation program. In bothcued with EBF lack expression of CD45R/B220, whereas
PU.1-rescued progenitors express CD45R/B220 (Sup- cases, the CD19 B cell precursors do not express
CD45R/B220. We suggest that in the case of IL-7Rplemental Figure S3A). A binding site for PU.1 has been
characterized upstream of the major transcription start transduction, IL-7R signaling promotes the survival/pro-
liferation of rare PU.1/ lymphoid progenitors and kinet-site utilized in myeloid and lymphoid cells (Anderson et
al., 2001). However, in this report, PU.1 was suggested ically delayed induction of EBF that then results in their
differentiation into CD19 B cell precursors. We noteto regulate CD45 expression in the myeloid but not
lymphoid compartments. In contrast, our results estab- that PU.1/ progenitors, if cultured directly on stroma
with IL-7 and SCF, can also give rise at low frequencylish that expression of CD45 as well as CD45R/B220 in
both the B and myeloid lineages is dependent on PU.1 and with delayed kinetics to B220 CD19 B cell precur-
sors (M. Ye and T. Graf, personal communication and(Supplemental Figure S3).
In EBF/ bone marrow, B cell development is arrested data not shown). On the other hand, EBF transduction
in PU.1/ lymphoid progenitors induces B cell develop-prior to the expression of B lineage genes and the onset
of IgH recombination (Lin and Grosschedl, 1995). Molec- ment without a kinetic delay. EBF likely promotes IL-7R
expression in concert with E2A. These results suggestular studies have implicated EBF in multiple aspects of
B cell development including regulation of Pax-5 and two independent modes of regulation (PU.1- or EBF-
dependent) of the IL-7R gene. Thus, a key function ofearly B lineage gene expression, mediating accessibility
of Ig recombination signals, and preventing heterochro- PU.1 is to control the generation of lymphoid progeni-
tors. In its absence, these progenitors are severely di-matin assembly (Lin and Grosschedl, 1995; Lundgren et
al., 2000; Romanow et al., 2000). We show in EBF/ minished, likely due to defective cytokine receptor ex-
pression (Flk2/Flt3 and IL-7R). Furthermore, based onembryos that IL-7R B220 cells are detectable at wild-
type frequency and can be propagated in vitro and dif- our results, we propose that PU.1/ lymphoid progeni-
tors are defective in undergoing B cell differentiationferentiated into B cell precursors upon complementation
with EBF. The IL-7R CD45R/B220 lymphoid progeni- because of impaired expression of the EBF gene. These
results illustrate similarities and differences in the roletors expanded from EBF/ embryos express normal
levels of PU.1 and E2A transcripts as well as low levels of PU.1 in the development of macrophages versus B
lymphocytes. In the myeloid compartment, PU.1 is re-of B29, but do not express Pax-5, mb-1, 5, VpreB, or
Rag-1/2 (Figure 6). Transduction of EBF in the EBF/ quired not only for the generation of myeloid progeni-
tors, but also for their differentiation into macrophagesprogenitors induces expression of all essential early B
lineage genes including CD19 and IgH recombination (DeKoter et al., 1998). In the lymphoid compartment,
PU.1 functions to generate lymphoid progenitors but is(Figure 6 and data not shown). Interestingly, Pax-5 was
unable to induce efficient expression of CD19 or mb-1 not directly required for their differentiation. The early
program of B cell-specific gene expression is largelyin EBF/ progenitors, suggesting that Pax-5 function in
activating these two genes is contingent on EBF. This independent of PU.1 and Spi-B and is promoted by E2A,
EBF, and Pax-5.model system employing EBF/ progenitors will facili-
tate a molecular analysis of the regulatory circuitry used Based on previous results and our new findings, we
propose a hierarchical regulatory circuitry for specifica-in specification of the B cell fate.
We demonstrate that EBF can restore expression of tion of the B cell fate (Figure 7). In our model, PU.1 and
Ikaros are suggested to induce the expression of Flk2/the Pax-5 gene, consistent with a previous report of
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Limiting Dilution AnalysisFlt3 in primitive hematopoietic progenitors. Signaling
After spin-infection, PU.1/ and PU.1/ FLPs were plated at varyingthrough Flk2/Flt3 promotes lymphoid specification and
dilutions on S17 stroma with IL-7 and analyzed after 10–14 days ofinduction of IL-7R in a PU.1-dependent manner. Within
culture. For analysis of B cell precursor frequency of c-kit AA4.1
the Flk2/Flt3 lymphoid progenitor, PU.1 and E2A coop- Flk2 and c-kit AA4.1 Flk2 populations, 5–200 cells were sorted
erate to activate EBF expression. We note that in PU.1 directly into the wells of plates containing 104 irradiated S17 cells
in medium supplemented with IL-7 (5 ng/ml), SCF (10 ng/ml), andmutants, few multipotential progenitors express or
FL (50 ng/ml). Six wells were analyzed with each cell concentrationachieve adequate levels of Flk2/Flt3 to signal expansion/
for production of CD19 cells after 8 days.survival of the lymphoid progenitor pool, nor are they
able to effectively induce EBF expression. In conjunction
Culture of EBF/ Lymphoid Progenitorswith PU.1, an alteration in E2A activity is likely critical
EBF/ lymphoid progenitors were propagated by plating FLPs from
for EBF expression and all subsequent events. The EBF/ day 14.5 embryos on irradiated S17 stromal cells in Optimem
mechanism by which this alteration is achieved remains medium (GIBCO-BRL) supplemented with 5% fetal calf serum, IL-7
to be uncovered. It has been suggested that E2A activity (5 ng/ml), and SCF (10 ng/ml).
(denoted as E2A*) is held in check in hematopoietic
RT-PCR Analysisprogenitors by dimerization with inhibitory bHLH pro-
Total RNA was isolated and converted into cDNA as describedteins including Id family members and Scl/Tal-1, as well
(DeKoter et al., 2002). All RT-PCR primers have been publishedas by Notch signaling (Allman et al., 2002; Massari and
except: EBF forward, GCCTTCTAACCTGCGGAAATC and reverse,
Murre, 2000). Once expressed at adequate levels, EBF GGCGCACATAGAAATCCTGTT; FL forward, CCAGCCTGGAGCC
acting in concert with E2A would activate the transcrip- CAAATTC and reverse, GGGCAGCAGGGTGGAGGAGTC; CD45/
tion of early B lineage genes as well as promote IgH CD45R, forward, CACTGTGTTATCTTGCCAAC and reverse, AGGCG
TGAGTGTGGGATTGTC.recombination resulting in specification of the B cell
fate. The final step in the hierarchical regulatory network
PCR Analysis of IgH Rearrangementwould involve activation of Pax-5 expression by EBF
PCR using genomic DNA was performed as described before (Me-and E2A. This would culminate in commitment to the B
dina et al., 2000). The primers used were -actin (Hardy et al., 1991),cell fate.
DHL (5) (Schlissel et al., 1991), JH4A (3) (Ehlich et al., 1994), and
7183, Q52, and J558 (5) (Schlissel et al., 1991).
Experimental Procedures
Gel Shift AssaysConstruction of Retroviral Vectors and Production
Nuclear extracts were made from 38B9 pro-B cells and gel shiftof Viral Supernatants
assays were performed as described (DeKoter et al., 2002).The MIGR1 and MIG-PU.1 retroviral vectors have been described
(DeKoter et al., 2002; Pear et al., 1998). The EBF and Pax-5 vectors
Chromatin Immunoprecipitation Assaysare derivatives of MIGR1. Retroviral supernatants were generated
Chromatin immunoprecipitation assays were performed as de-by calcium phosphate transfection of the packaging cell line Plat-E
scribed with minor modifications (DeKoter et al., 2002). The EBFand titered using NIH-3T3 cells (Morita et al., 2000; Walsh et al.,
gene primers are forward, TGGCCAGGCTCTGTGAACA and reverse,2002). Equivalent titers were used for infection. GPE-86 packaging
TCTTTCCTTTCCGTGCGTGTA.cells were used to generate MIG-EBF and MIG-Pax5 viral producer
lines (DeKoter et al., 2002).
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Note Added in Proof
We note that Maier et al. (Maier, H., Ostraat, R., Gao, H., Fields, S.,
Shinton, S.A., Medina, K.L., Ikawa, T., Murre, C., Singh, H., Hardy,
R.R., and Hagman, J. (2004). Early B cell factor cooperates with
Runx1 and mediates epigenetic changes associated with mb-1 tran-
scription. Nat. Immunol., in press. Published online September 12,
2004. 10.1038/ni1119) have uncovered a molecular mechanism reg-
ulating mb-1 gene transcription, which is consistent with the hierar-
chical dependence of Pax-5 function on EBF, demonstrated herein.
